Posted by Michael Wonder on 19 Oct 2022
Oestradiol hemifumarate with norethisterone acetate and relugolix for the treatment of moderate to severe symptoms of uterine fibroids
19 October 2022 - NICE has published evidence based recommendations on the use of oestradiol hemifumarate with norethisterone acetate and relugolix for the treatment of adults of reproductive age with moderate to severe symptoms of uterine fibroids.
Oestradiol hemifumarate with norethisterone acetate and relugolix is recommended as an option for the treatment of adults of reproductive age. moderate to severe symptoms of uterine fibroids.
